(244 days)
Not Found
No
The 510(k) summary describes a mechanical knee implant system and its materials, intended use, and performance testing. There is no mention of software, algorithms, image processing, or any other indicators of AI/ML technology.
Yes
The device, the Tahoe Unicompartmental Knee System (TUKS), is an implant designed for "primary medial or lateral compartmental intervention" for various degenerative knee conditions, which aligns with the definition of a therapeutic device as it is intended to treat or alleviate a medical condition.
No
The Tahoe Unicompartmental Knee System (TUKS) is a surgical implant designed for knee replacement, not for diagnosing medical conditions. It is used to treat existing conditions like osteoarthritis or traumatic arthritis.
No
The device description clearly states it is a system of physical implants made from materials like CoCr alloy and UHMWPE, intended for surgical implantation. It also describes bench testing and FEA simulations related to the physical components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for treating knee conditions. IVDs are used to examine specimens from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Device Description: The device is described as a knee implant system made of materials like CoCr alloy and UHMWPE. This is consistent with a medical device intended for implantation, not for testing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, calibrators, controls, or any other components typically associated with IVD devices.
- Performance Studies: The performance studies described (bench testing, FEA simulations, fatigue testing, contact characteristics) are relevant to the mechanical and structural integrity of an implant, not the analytical performance of an IVD.
In summary, the Tahoe Unicompartmental Knee System is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Tahoe Unicompartmental Knee System (TUKS) is designed as a system and is not intended for substitution of components from other systems. The indications for use are as follows:
Primary medial or lateral compartmental intervention of (1) primary non-inflammatory degenerative disease, including osteoarthritis, traumatic arthritis, or osteonecrosis; (2) posttraumatic degenerative disease; (3) varus or valgus deformities; and (4) damage due to previous surgical intervention when the opposite compartment is preserved and when the anterior cruciate, posterior cruciate, medial collateral, and lateral collateral ligaments are present and functional.
All TUKS implants are single use only, and are intended for implantation only with bone cement.
Product codes
HSX
Device Description
The Tahoe Uni Knee System (TUKS) is a primary fixed-bearing, round-on-flat unicompartmental knee system offering flexibility to restore function in the affected medial or lateral tibial compartments. The femoral and tibial components are intended use only. The femoral component is made from cast CoCr alloy (ASTM F75), whereas the tibial baseplate is made from wrought CoCr alloy (ASTM F1537). The tibial insert is made from UHMWPE (ASTM F648) or Vitamin-E polyethylene (VitalitE, ASTM F2695). The tibial insert is designed to snap into the baseplate via an anterior-posterior locking mechanism.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Knee joint, femorotibial, tibial compartments
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench testing, FEA simulations, and engineering justifications were carried out on TUKS implant components to ensure their safety and effectiveness for clinical use. The femoral component was analyzed via FEA simulation to ensure its backside geometry (tensile side) would not fail when deflecting the posterior facet away from the central peg. The tibial baseplate was fatigue tested in 3-point bending per WK45235 to ensure the tray region would not fail under the absence of bone support on the tibial plateau mid-section. Joint stability testing was deemed unnecessary due to the unconstrained round-on-flat articulation. Joint contact characteristics were tested per ASTM F2083-12 to ensure adequate tibiofemoral contact area and contact pressure distribution under physiologic load. The tibial insert locking mechanism was tested to ensure ease of manual insertion and adequate connection strength. Wear testing was deemed unnecessary due to meeting the minimum requirement for poly thickness in the load bearing region (6mm) per ISO 21536. Pyrogenicity testing was completed and was deemed to be within 20 Endotoxin Units per surgical construct per the FDA Guidance Document Pyrogen and Endotoxins Testing.
Key Metrics
Not Found
Predicate Device(s)
K050764, K971938, K021621, K042093, K022437, K020741, K123380
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3520 Knee joint femorotibial metal/polymer non-constrained cemented prosthesis.
(a)
Identification. A knee joint femorotibial metal/polymer non-constrained cemented prosthesis is a device intended to be implanted to replace part of a knee joint. The device limits minimally (less than normal anatomic constraints) translation in one or more planes. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral condylar resurfacing component or components made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components made of ultra-high molecular weight polyethylene and are intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Consensus Orthopedics, Inc Zac Johnson Regulatory Affairs Specialist 1115 Windfield Wav El Dorado Hills, California 95762 October 5, 2017
Re: K170344
Trade/Device Name: Tahoe Uni Knee System Regulation Number: 21 CFR 888.3520 Regulation Name: Knee joint femorotibial metal/polymer non-constrained cemented prosthesis Regulatory Class: Class II Product Code: HSX Dated: September 7, 2017 Received: September 7, 2017
Dear Mr. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevicesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
UDICATIONS FOO USE STATEN
510(k) Number: K170344
Device Name: Tahoe Uni Knee Syste
INDICATIONS AND USAGE
:swollot se are asu rof suoitesibui ad T :smetsys redto mort strenodimos i və qalında və bəbinə qalınmış və sə bənşisən si (SXUT) mətriy əsərlərin əsasən inil ədədi ədə
collaters), and lateral collateral liigaments are pressut and functional. ibem , and services on is not is no the not no the not member of institution is also do นอนพ แอฟเซอร์เท่ ไธวเป็นทรางงาน อา อนุม อริธเทพ (b) but : รอยู่ใหม่เข้าอุประเทศ เป็นเทพ (c) :อรออรib ຣາອາອົງອີງ ການປະກວດ (S) ; ເຂດາວອາດອາຣາ ເດີຍນາ ເປັນນາງງາມ ເປັນເປັນເອກະສາປີ ເ əvizesən vəzirlərindən yaranmışdır. İstinadlar Həmçinin baxında baxında bir və bir və bir və bir və bir və bir və
unun ən qalını və qalında və başların ərə bura şirkət ərazi və bir sənələri ilə bir və bir sənələri ilə bir və
IZ) and and and and and and and and
IO/ANA
Over the Counter Use CFR Part 801 Suppart
аасаан эг ээлч язнтома по эпитиог гэмт гэнт молав этгийн том оа
וחבות של CDPH, Office of Device Evaluation (ODF
3
2. 510(k) SUMMARY
| Sponsor Name: | Consensus Orthopedics, Inc.
1115 Windfield Way, Suite 100
El Dorado Hills, CA 95762 |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Contact: | Name: Zac Johnson
Phone: (916) 355-7154
Fax: (916) 355-7190
Email: zjohnson@consensusortho.com |
| Date Prepared: | 01 February 2017 |
| Trade Name: | Tahoe Uni Knee System |
| Common Name: | Unicompartmental Knee System |
| Classification Name: | Knee joint femorotibial metal/polymer non-constrained cemented
prosthesis; Class II device; 21 CFR 888.3520; Product Code: HSX |
Device Description:
The Tahoe Uni Knee System (TUKS) is a primary fixed-bearing, round-on-flat unicompartmental knee system offering flexibility to restore function in the affected medial or lateral tibial compartments. The femoral and tibial components are intended use only. The femoral component is made from cast CoCr alloy (ASTM F75), whereas the tibial baseplate is made from wrought CoCr alloy (ASTM F1537). The tibial insert is made from UHMWPE (ASTM F648) or Vitamin-E polyethylene (VitalitE, ASTM F2695). The tibial insert is designed to snap into the baseplate via an anterior-posterior locking mechanism.
Indications for Use:
The Tahoe Unicompartmental Knee System (TUKS) is designed as a system and is not intended for substitution of components from other systems. The indications for use are as follows:
Primary medial or lateral compartmental intervention of (1) primary non-inflammatory degenerative disease, including osteoarthritis, traumatic arthritis, or osteonecrosis; (2) posttraumatic degenerative disease; (3) varus or valgus deformities; and (4) damage due to previous surgical intervention when the opposite compartment is preserved and when the anterior cruciate, posterior cruciate, medial collateral, and lateral collateral ligaments are present and functional.
All TUKS implants are single use only, and are intended for implantation only with bone cement.
4
Substantial Equivalence:
Technological Characteristics/ Substantial Equivalence:
The Tahoe Uni Knee System (TUKS) implant components are substantially equivalent to legally marketed devices regarding their indications, technology, and performance (Table 4.1). The TUKS is substantially equivalent to the following unicompartmental knee systems intended for cemented use:
- Uniglide Femoral component used with all-poly tibial component (K050764). ●
- Oxford Femoral component used with Repicci II (K971938) or Vanguard M Series ● (K021621, K042093) metal-backed tibial components.
- EPIK Metal-backed tibial component (K022437; K020741). ●
- Stride - Metal-backed tibial component (K123380).
Non-Clinical Performance Data:
Bench testing, FEA simulations, and engineering justifications were carried out on TUKS implant components to ensure their safety and effectiveness for clinical use. The femoral component was analyzed via FEA simulation to ensure its backside geometry (tensile side) would not fail when deflecting the posterior facet away from the central peg. The tibial baseplate was fatigue tested in 3-point bending per WK45235 to ensure the tray region would not fail under the absence of bone support on the tibial plateau mid-section. Joint stability testing was deemed unnecessary due to the unconstrained round-on-flat articulation. Joint contact characteristics were tested per ASTM F2083-12 to ensure adequate tibiofemoral contact area and contact pressure distribution under physiologic load. The tibial insert locking mechanism was tested to ensure ease of manual insertion and adequate connection strength. Wear testing was deemed unnecessary due to meeting the minimum requirement for poly thickness in the load bearing region (6mm) per ISO 21536. Pyrogenicity testing was completed and was deemed to be within 20 Endotoxin Units per surgical construct per the FDA Guidance Document Pyrogen and Endotoxins Testing.